Copyright
        ©The Author(s) 2024.
    
    
        World J Nephrol. Dec 25, 2024; 13(4): 99700
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99700
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.99700
            Table 1 The relationship between lupus nephritis and pregnancy
        
    | Risk of lupus to pregnancy | Risk of pregnancy to lupus | 
| Pregnancy loss | Lupus flares | 
| Pre-term delivery | Progressive renal disease | 
| Eclampsia | Maternal thromboembolism | 
| Neonatal lupus due to Ro and La antibodies | 
            Table 2 Lupus nephritis in pregnancy: Evaluation and monitoring
        
    | Before pregnancy | Every 6-8 weeks (adjustable)1 | 
| Complete metabolic panel | Complete metabolic panel | 
| Prothrombin time/partial thromboplastin time | |
| 24-h urinary protein and creatinine clearance2 | |
| sPCR | sPCR | 
| Anti-dsDNA | Anti-dsDNA | 
| Anti-Ro/SS-A and anti-La/SS-B antibodies | |
| Lupus anticoagulant3 | |
| Anticardiolipin IgG, IgM, IgA3 | |
| Anti-β2 glycoprotein I IgG, IgM, IgA3 | |
| Complement levels (C3, C4) | Complement levels (C3, C4) | 
| Uric acid | Uric acid | 
| Urine detailed report with microscopy | Urine detailed report with microscopy | 
            Table 3 Medication compatibility with pregnancy and lactation
        
    | Medications | Before conception | During pregnancy | Lactation | 
| Stop at conception | |||
| Abatacept | Stop with the positive pregnancy test | + | |
| Belimumab | Stop with the positive pregnancy test | + | |
| Rituximab | Stop with the positive pregnancy test | + | |
| Compatible drugs | |||
| Hydroxychloroquine | + | + | + | 
| Azathioprine | + | + | + | 
| Cyclosporine | + | + | + | 
| Tacrolimus | + | + | + | 
| Sulfasalazine | + | + | + | 
| Prednisone | Dose < 20 mg/day | Dose < 20 mg/day | Dose < 20 mg/day | 
| NSAIDs | Discontinue w/difficulty conceiving | Stop at week 20 | + | 
| Non-compatible drugs | |||
| Cyclophosphamide | Stop 3 months before conception | x | x | 
| MMF/mycophenolic acid | Stop 6 weeks before conception | x | x | 
| Methotrexate | Stop 1-3 months before conception | x | x low transfer into breast milk | 
            Table 4 Features important in differentiating lupus nephritis from pre-eclampsia
        
    | Features | Lupus nephritis | Pre-eclampsia | 
| Timing | Any time during pregnancy | After 20 weeks of gestation | 
| Hypertension | Can be present or absent | Always present | 
| Other organ involvement | Present (e.g., skin, joints) | Absent | 
| Complement levels (C3, C4) | Decreased or normal | Normal | 
| Anti-dsDNA | Positive | Negative | 
| Lupus serology | Active disease markers present | Usually absent | 
| Active urinary sediment Urinary calcium Response to steroids  | Present | Absent | 
| > 195 mg/d | < 195 mg/d | |
| Generally responsive | No response | |
| Platelet count | Usually normal or mildly low | Often low (thrombocytopenia) | 
| Liver enzymes | Usually normal | Elevated (HELLP syndrome) | 
- Citation: Elahi T, Ahmed S, Mubarak M. Relationship of lupus nephritis and pregnancy: A narrative review. World J Nephrol 2024; 13(4): 99700
 - URL: https://www.wjgnet.com/2220-6124/full/v13/i4/99700.htm
 - DOI: https://dx.doi.org/10.5527/wjn.v13.i4.99700
 
